Cargando…
Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor
The pathogenesis of gastroesophageal reflux disease (GERD) is not fully understood. It involves the activation of mucosal immune-mediated and inflammatory responses. Toll-like receptors (TLR) 2 and TLR4 are pattern-recognition receptors of the innate immune system; they recognize microbial and endog...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364528/ https://www.ncbi.nlm.nih.gov/pubmed/33686512 http://dx.doi.org/10.1007/s00428-021-03066-w |
_version_ | 1783738545301618688 |
---|---|
author | Nortunen, Minna Väkiparta, Nina Porvari, Katja Saarnio, Juha Karttunen, Tuomo J Huhta, Heikki |
author_facet | Nortunen, Minna Väkiparta, Nina Porvari, Katja Saarnio, Juha Karttunen, Tuomo J Huhta, Heikki |
author_sort | Nortunen, Minna |
collection | PubMed |
description | The pathogenesis of gastroesophageal reflux disease (GERD) is not fully understood. It involves the activation of mucosal immune-mediated and inflammatory responses. Toll-like receptors (TLR) 2 and TLR4 are pattern-recognition receptors of the innate immune system; they recognize microbial and endogenous ligands. Farnesoid X receptor (FXR) is a bile acid receptor that regulates the inflammatory response. We aimed to evaluate TLR2, TLR4 and FXR expression patterns in GERD. We re-evaluated 84 oesophageal biopsy samples according to the global severity (GS) score, including 26 cases with histologically normal oesophagus, 28 with histologically mild oesophagitis and 30 with severe oesophagitis. We used immunohistochemistry and in situ hybridization to assess the expression patterns of TLR2, TLR4 and FXR in oesophageal squamous cells. Immunohistochemistry showed that nuclear and cytoplasmic TLR2 was expressed predominantly in the basal layer of normal oesophageal epithelium. In oesophagitis, TLR2 expression increased throughout the epithelium, and the superficial expression was significantly more intensive compared to normal epithelium, p <0.01. Nuclear and cytoplasmic TLR4 was expressed throughout the thickness of squamous epithelium, with no change in oesophagitis. FXR was expressed in the nuclei of squamous cells, and the intensity of the expression increased significantly in oesophagitis (p <0.05). FXR expression correlated with basal TLR2. In situ hybridization confirmed the immunohistochemical expression patterns of TLR2 and TLR4. In GERD, TLR2, but not TLR4, expression was upregulated which indicates that innate immunity is activated according to a specific pattern in GERD. FXR expression was increased in GERD and might have a regulatory connection to TLR2. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00428-021-03066-w. |
format | Online Article Text |
id | pubmed-8364528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-83645282021-08-19 Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor Nortunen, Minna Väkiparta, Nina Porvari, Katja Saarnio, Juha Karttunen, Tuomo J Huhta, Heikki Virchows Arch Original Article The pathogenesis of gastroesophageal reflux disease (GERD) is not fully understood. It involves the activation of mucosal immune-mediated and inflammatory responses. Toll-like receptors (TLR) 2 and TLR4 are pattern-recognition receptors of the innate immune system; they recognize microbial and endogenous ligands. Farnesoid X receptor (FXR) is a bile acid receptor that regulates the inflammatory response. We aimed to evaluate TLR2, TLR4 and FXR expression patterns in GERD. We re-evaluated 84 oesophageal biopsy samples according to the global severity (GS) score, including 26 cases with histologically normal oesophagus, 28 with histologically mild oesophagitis and 30 with severe oesophagitis. We used immunohistochemistry and in situ hybridization to assess the expression patterns of TLR2, TLR4 and FXR in oesophageal squamous cells. Immunohistochemistry showed that nuclear and cytoplasmic TLR2 was expressed predominantly in the basal layer of normal oesophageal epithelium. In oesophagitis, TLR2 expression increased throughout the epithelium, and the superficial expression was significantly more intensive compared to normal epithelium, p <0.01. Nuclear and cytoplasmic TLR4 was expressed throughout the thickness of squamous epithelium, with no change in oesophagitis. FXR was expressed in the nuclei of squamous cells, and the intensity of the expression increased significantly in oesophagitis (p <0.05). FXR expression correlated with basal TLR2. In situ hybridization confirmed the immunohistochemical expression patterns of TLR2 and TLR4. In GERD, TLR2, but not TLR4, expression was upregulated which indicates that innate immunity is activated according to a specific pattern in GERD. FXR expression was increased in GERD and might have a regulatory connection to TLR2. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00428-021-03066-w. Springer Berlin Heidelberg 2021-03-08 2021 /pmc/articles/PMC8364528/ /pubmed/33686512 http://dx.doi.org/10.1007/s00428-021-03066-w Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Article Nortunen, Minna Väkiparta, Nina Porvari, Katja Saarnio, Juha Karttunen, Tuomo J Huhta, Heikki Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor |
title | Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor |
title_full | Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor |
title_fullStr | Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor |
title_full_unstemmed | Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor |
title_short | Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor |
title_sort | pathophysiology of reflux oesophagitis: role of toll-like receptors 2 and 4 and farnesoid x receptor |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364528/ https://www.ncbi.nlm.nih.gov/pubmed/33686512 http://dx.doi.org/10.1007/s00428-021-03066-w |
work_keys_str_mv | AT nortunenminna pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor AT vakipartanina pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor AT porvarikatja pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor AT saarniojuha pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor AT karttunentuomoj pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor AT huhtaheikki pathophysiologyofrefluxoesophagitisroleoftolllikereceptors2and4andfarnesoidxreceptor |